UroGen Pharma - Bathi operasional EBITDA URGN
UroGen Pharma Ltd. (URGN) focuses on developing unique therapies for urological oncology in the US. The use of proprietary slow-release gels ensures high sales margins. Meanwhile, the humanitarian status of the drugs minimizes the impact of global trade disputes. The absolute EBITDA trend demonstrates the business's real cash flow, where the 0.00 metric determines this level.
Ringkesan rincian data analitis UroGen Pharma (URGN)
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal UroGen Pharma Ltd.|URGN - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal UroGen Pharma Ltd|URGN - Utang perusahaan|Utang-utang marang nilai buku UroGen Pharma|URGN - Utang jangka dawa perusahaan|Tanggungan jangka cendhak UroGen Pharma|Likuiditas darurat urogen.com
- statistik bathi lan rasio pasar:
URGN - Bathi resik perusahaan|Prakiraan bathi resik UroGen Pharma Ltd.|URGN - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi urogen.com|URGN - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan UroGen Pharma|URGN - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku UroGen Pharma|URGN - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan urogen.com|URGN - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep UroGen Pharma Ltd.
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis kabeh metrik perusahaan:UroGen Pharma Ltd.
The deployment of automated packaging lines and the implementation of software robots at UroGen Pharma Ltd. (URGN) directly impact operational efficiency. The EBITDA financial metric on GURU.Markets measures net cash flow from core operations, excluding the impact of taxes, depreciation, and borrowing costs. The current value of 0.00 reflects the business's actual ability to generate cash amid the Fed's tight monetary policy. The trend of this metric allows for an assessment of the company's speed of adaptation to high borrowing costs, which determines the fundamental stability of the issuer's market value.
Karo sapa UroGen Pharma Ltd. saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|BCAX (Bicara Bio) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Personalis Genomics PSNL|Bathi operasional sadurunge ngurangi amortisasi ERAS (Erasca, Inc.)|Bathi operasional EBITDA delcath.com (DCTH)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Y-mAbs Therapeutics, Inc. YMAB|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi AURA|CADL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Accuray, Inc.|SLS: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi actuatetherapeutics.com ACTU|CTOR (Citius Oncology) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi TuHURA HURA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Protara (TARA)|Fate Pharma - Bathi operasional sadurunge amortisasi|Aadi Bioscience - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TCRX|CSBR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi XBIT|CVM: Bathi operasional EBITDA|OS Therapies, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|RADX (Radiopharm Theranostics) - Bathi operasional EBITDA|Bathi operasional EBITDA Artiva|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Adlai Nortye Ltd. (ANL)|VERU (Veru Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tempest Tx TPST|XLO - Bathi operasional sadurunge ngurangi amortisasi|Enochian BioSciences - Bathi operasional EBITDA|MURA - Bathi operasional EBITDA|KAPA (kairospharma.com) - Bathi operasional sadurunge ngurangi amortisasi|OnKure Therapeutics - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CytoMed Therapeutics Ltd|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CRIS|Bathi operasional sadurunge ngurangi amortisasi APLM (Apollomics, Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi THAR|Bathi operasional EBITDA ADVB (Advanced Biomed)|GNPX: Bathi operasional sadurunge amortisasi|CLDI: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi sunshinebiopharma.com SBFM|XBIO (xeneticbio.com) - Bathi operasional sadurunge ngurangi amortisasi|salariuspharma.com (SLRX) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Purple Biotech Ltd.|AONC: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA BGNE|Checkpoint Therapeutics Inc (CKPT) - Bathi operasional sadurunge potongan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|ICAD: Bathi operasional sadurunge amortisasi|Ikena - Bathi operasional EBITDA|Notable Labs Ltd (NTBL) - Bathi operasional sadurunge ngurangi amortisasi|VIRX: Bathi operasional EBITDA|MorphoSys Corporation (MOR) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAYA Biosciences|Bathi operasional sadurunge amortisasi AAPGV (ascentage.com)
